Evidence map›Paper›PMID 31683744›Full record

ArticleCells2019

Interaction of Pregnancy-Specific Glycoprotein 1 With Integrin Α5β1 Is a Modulator of Extravillous Trophoblast Functions.

Shemona Rattila, Caroline E E Dunk, Michelle Im, Olga Grichenko, Yan Zhou, Maria Yanez-Mo, Sandra M Blois, Kenneth M Yamada, Offer Erez, Nardhy Gomez-Lopez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. International journal of molecular sciences · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Placenta: an old organ with new functions.Frontiers in immunology · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Human Chorionic Villous Differentiation and Placental Development.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 6 countries.

Shemona RattilaDepartment of Pathology, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA. sandra.blois@gmail.com.
Caroline E E DunkLunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5T 3H7, Canada. sandra.blois@gmail.com.
Michelle ImLaboratory of Tissue Repair and Regeneration, Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada. sandra.blois@gmail.com.
Olga GrichenkoDepartment of Pathology, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA. sandra.blois@gmail.com.
Yan ZhouDepartment of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, University of California San Francisco, San Francisco, CA 94143, USA. sandra.blois@gmail.com.
Maria Yanez-MoDepartment of Molecular Biology, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain. sandra.blois@gmail.com.
Sandra M BloisExperimental and Clinical Research Center, a Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, and the Charité-Universitätsmedizin Berlin, AG GlycoImmunology, 13125 Berlin, Germany. sandra.blois@gmail.com.
Kenneth M YamadaCell Biology Section, National Institute of Dental and Craniofacial Research, National Institute of Health, Bethesda, MD 20892, USA. kyamada@dir.nidcr.nih.gov.
Offer ErezPerinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD 20892, USA, and Detroit, MI 48201, USA. offererez@gmail.com.
Nardhy Gomez-LopezPerinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD 20892, USA, and Detroit, MI 48201, USA. ngomezlo@med.wayne.edu.
Stephen J LyeLunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5T 3H7, Canada. Lye@lunenfeld.ca.
Boris HinzLaboratory of Tissue Repair and Regeneration, Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada. boris.hinz@utoronto.ca.
Roberto RomeroDepartment of Obstetrics and Gynecology, University of Michigan Health System, Ann Arbor, MI 48109, USA. prbchiefstaff@med.wayne.edu.
Marie CohenDepartment of Pediatrics, Gynecology and Obstetrics, University of Geneva, 1206 Geneva, Switzerland. gabriela.dveksler@usuhs.edu.
Gabriela DvekslerDepartment of Pathology, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA. gabriela.dveksler@usuhs.edu.
Uniformed Services University of the Health Sciences · USLunenfeld-Tanenbaum Research Institute · CAUniversity of Toronto · CABen-Gurion University of the Negev · ILMax Delbrück Center · DENational Institute of Dental and Craniofacial Research · USNational Institutes of Health · USUniversidad Autónoma de Madrid · ESUniversity of California, San Francisco · USUniversity of Geneva · CHWayne State University · US

Funding

CIHR 375597CIHR FDN-143262CIHR MGC-13299NICHD NIH HHS HHSN275201300006C
6 · The paper itself

Abstract

Human pregnancy-specific glycoproteins (PSGs) serve immunomodulatory and pro-angiogenic functions during pregnancy and are mainly expressed by syncytiotrophoblast cells. While PSG mRNA expression in extravillous trophoblasts (EVTs) was reported, the proteins were not previously detected. By immunohistochemistry and immunoblotting, we show that PSGs are expressed by invasive EVTs and co-localize with integrin 5. In addition, we determined that native and recombinant PSG1, the most highly expressed member of the family, binds to 51 and induces the formation of focal adhesion structures resulting in adhesion of primary EVTs and EVT-like cell lines under 21% oxygen and 1% oxygen conditions. Furthermore, we found that PSG1 can simultaneously bind to heparan sulfate in the extracellular matrix and to 51 on the cell membrane. Wound healing assays and single-cell movement tracking showed that immobilized PSG1 enhances EVT migration. Although PSG1 did not affect EVT invasion in the in vitro assays employed, we found that the serum PSG1 concentration is lower in African-American women diagnosed with early-onset and late-onset preeclampsia, a pregnancy pathology characterized by shallow trophoblast invasion, than in their respective healthy controls only when the fetus was a male; therefore, the reduced expression of this molecule should be considered in the context of preeclampsia as a potential therapy.

Indexed as

Cell AdhesionCell LineCell MembraneCell MovementExtracellular MatrixFemaleFocal Adhesion Protein-Tyrosine KinasesHeparan SulfateHumansImmobilized ProteinsIntegrin alpha5beta1PlacentaPre-EclampsiaPregnancyPregnancy-Specific beta 1-GlycoproteinsPregnancy Trimester, FirstFocal Adhesion Protein-Tyrosine KinasesHeparan SulfateImmobilized ProteinsIntegrin alpha5beta1Pregnancy-Specific beta 1-Glycoproteinsadhesionextravillous trophoblastsintegrin α5β1migrationpreeclampsiapregnancy-specific glycoproteins

Identifiers

PMID31683744
PMCPMC6912793
OpenAlexW2982612901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.